Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC
about
PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer.HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.Dual inhibiting OCT4 and AKT potently suppresses the propagation of human cancer cells.Epothilone B induces apoptosis and enhances apoptotic effects of ABT-737 on human cancer cells via PI3K/AKT/mTOR pathway.HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells.RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition.Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma.The anti-tumor effects of dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A on inducing autophagy in esophageal squamous cell carcinoma.
P2860
Q37707021-76E93B46-FE3E-4312-81BA-0F6E7DEF6A0AQ37718484-64D749FC-982A-4C92-8818-00429C4144C3Q37739700-8AF31C12-293E-4598-B166-5B30AFCFCB66Q38748411-FC921BF0-0E39-45C3-B69C-757AD585C89BQ47100939-E3ECB752-50F5-46D8-B079-BB2CD639BE89Q48123819-82E7D865-90EB-4BA0-8018-42FD9B3C8371Q49240447-D02843CC-1D27-48AA-A00F-2CF3A638A055Q52629243-7AA496CA-93C3-48E6-B6BE-944827DE3C73
P2860
Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Superior efficacy of co-treatm ...... r Trichostatin A against NSCLC
@en
Superior efficacy of co-treatm ...... Trichostatin A against NSCLC.
@nl
type
label
Superior efficacy of co-treatm ...... r Trichostatin A against NSCLC
@en
Superior efficacy of co-treatm ...... Trichostatin A against NSCLC.
@nl
prefLabel
Superior efficacy of co-treatm ...... r Trichostatin A against NSCLC
@en
Superior efficacy of co-treatm ...... Trichostatin A against NSCLC.
@nl
P2093
P2860
P356
P1433
P1476
Superior efficacy of co-treatm ...... r Trichostatin A against NSCLC
@en
P2093
Chunji Quan
Junjie Piao
Liyan Chen
Longshan Li
Taihao Quan
Tiefeng Jin
Yingshi Piao
Zhenhua Lin
P2860
P304
60169-60180
P356
10.18632/ONCOTARGET.11109
P407
P577
2016-08-06T00:00:00Z